跳至主要内容
临床试验/NCT01341951
NCT01341951Unknown不适用

G-CSF in Acute Liver Failure and Alcoholic Hepatitis - A Pilot Study

Post Graduate Institute of Medical Education and Research, Chandigarh1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2010年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
60
试验地点
1
主要终点
• Mobilization of CD34 cells in the peripheral blood, a surrogate marker for hematopoietic stem cell mobilization

研究概览

简要总结

Granulocyte colony stimulating factor in acute liver failure and alcoholic hepatitis

详细描述

In this study 4 groups have been taken. Two groups of cases including Alcoholic patients and acute liver failure which are given G-CSF therapy and two groups of controls given standard therapy. Primary end point is to see the mobilization of CD-34 hematopoietic cells and survival. Secondary end point is to see the clinical and biochemical improvement in liver functions.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with Acute Liver failure as defined by AASLD.65
  • Patients with Alcoholic hepatitis defined as follows: decades of heavy alcohol use (mean intake, approximately 100 g per day).The combination of an aspartate aminotransferase level that is elevated (but <300 IU per milliliter) and a ratio of the aspartate aminotransferase level to the alanine aminotransferase level that is more than 2, a total serum bilirubin level of more than 5 mg per deciliter (86 μmol per liter), an elevated INR, and neutrophilia.

排除标准

  • Known hypersensitivity to filgrastim
  • creatinine > 150 µmol/L
  • infection or hemorrhage within the last 10 days
  • documented hepatocellular carcinoma
  • hepatitis B,C or human immunodeficiency virus seropositivity and pregnancy

研究组 & 干预措施

G-CSF therapy in acute liver failure and alcoholic hepatitis

Experimental

G-CSF therapy given in cases with acute liver failure and alcoholic hepatitis

干预措施: Granulocyte colony stimulating factor (Drug)

结局指标

主要结局

• Mobilization of CD34 cells in the peripheral blood, a surrogate marker for hematopoietic stem cell mobilization

时间窗: 1 year

次要结局

  • clinical and biochemical improvement in liver functions(1 year)

研究者

发起方
Post Graduate Institute of Medical Education and Research, Chandigarh
申办方类型
Other

研究点 (1)

Loading locations...

相似试验